You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
08
May 24
Publication quarterly financial report (call-date Q1)
17
Annual General Meeting
31
Jul 24
Publication half-yearly financial report
06
Nov 24
Publication quarterly financial report (call-date Q3)
14
Mar 24
Publication annual financial report
21
Feb 24
Analysts’ Conference
Nov 23
02
Press Release – quarterly financial report (call-date Q3)
04
Aug 23
Press Release – half-yearly financial report
May 23
11
09
Press Release – quarterly financial report (call-date Q1)
23
Mar 23
22
Feb 23
Press Release – annual financial report
03
Nov 22
01
Aug 22
13
May 22
24
Mar 22
Feb 22
Nov 21
Conference Call
Aug 21
30
Jul 21
07
May 21
18
Mar 21
Feb 21
4 April 2024
Fresenius SE & Co. KGaA: Robert Möller, buy
Fresenius SE & Co. KGaA: Pierluigi Antonelli, buy
Fresenius SE & Co. KGaA: Sara Hennicken, buy
Fresenius SE & Co. KGaA: Michael Sen, buy
2 April 2024
Fresenius SE & Co. KGaA: Announcement of the Convening of the General Meeting in Frankfurt am Main on 17.05.2024 according to article 121 AktG (German Stock Companies Act) with the objective of Europe-wide distribution
13 March 2024
Fresenius SE & Co. KGaA: Dr. Frank Appel, buy
19 March 2024
Annual financial report 2023
6 November 2023
Q3 statement / Q3 financial report 2023
4 August 2023
Half-yearly financial report 2023
Apr 08
Fresenius Kabi Expands I.V. Drug Portfolio
